Mehrdad Sheikhvatan | Genetics | Research Excellence Award

Research Excellence Award

Mehrdad Sheikhvatan

Istanbul Okan University, Turkey

Mehrdad Sheikhvatan
Affiliation Istanbul Okan University
Country Turkey
Scopus ID QyAoxqEAAAAJ
Documents 163
Citations 2326
h-index 25
Subject Area Genetics
Event Global Academic Awards

Mehrdad Sheikhvatan is an academic researcher affiliated with Istanbul Okan University whose scholarly contributions have demonstrated sustained engagement within the field of genetics and related biomedical sciences. His publication profile reflects interdisciplinary collaboration, scientific productivity, and ongoing participation in international research activities. Through peer-reviewed publications, citation impact, and academic visibility, Sheikhvatan has contributed to advancing scientific understanding in areas associated with molecular biology, genetics, and translational biomedical research.[1] The research profile presented in this article summarizes the candidate’s scholarly background, publication activity, research impact indicators, and suitability for recognition under the Research Excellence Award category within the Global Academic Awards framework.[2]

Abstract

This academic article presents a structured overview of the scholarly profile and research achievements of Mehrdad Sheikhvatan in relation to the Research Excellence Award category. The article evaluates the candidate’s scientific productivity, publication metrics, interdisciplinary engagement, and contribution to genetics and biomedical sciences. The assessment incorporates publication counts, citation performance, h-index indicators, and evidence of sustained academic participation in peer-reviewed research activities.[1] The analysis further considers the relevance of the researcher’s work within contemporary scientific discourse and international academic collaboration.[3]

Keywords

Genetics, Biomedical Research, Molecular Biology, Scientific Publications, Citation Analysis, Research Excellence, Academic Recognition, Translational Medicine, Scholarly Impact, Interdisciplinary Science

Introduction

The recognition of scholarly achievement through international academic awards serves an important role in encouraging scientific innovation, interdisciplinary collaboration, and research dissemination. Within the biomedical sciences, researchers who demonstrate sustained publication activity and measurable scientific influence contribute significantly to the advancement of global knowledge systems.[2] Mehrdad Sheikhvatan has established a research profile characterized by active engagement in genetics and associated biomedical domains through collaborative studies, publication output, and scholarly visibility.[4]

Academic performance indicators such as citation counts, publication productivity, and h-index measurements are commonly employed to evaluate the scholarly relevance of researchers within international academic frameworks. In this context, Sheikhvatan’s profile reflects a combination of research continuity and interdisciplinary participation that aligns with contemporary expectations for research excellence awards.[1]

Research Profile

Mehrdad Sheikhvatan is affiliated with Istanbul Okan University in Turkey and has contributed to scientific literature across genetics and biomedical research disciplines. The researcher has authored or co-authored a substantial number of scholarly publications indexed within international academic databases.[1] The publication record indicates involvement in collaborative scientific investigations that integrate clinical, molecular, and translational perspectives within healthcare-related research contexts.[5]

The researcher’s academic profile includes 163 indexed documents accompanied by 2326 citations and an h-index of 25, reflecting a measurable level of scholarly influence and citation visibility within the research community.[1] Such metrics suggest sustained engagement in research dissemination and continuing contribution to evolving scientific discussions in genetics and related biomedical areas.

Research Contributions

The scientific contributions associated with Mehrdad Sheikhvatan encompass collaborative biomedical investigations and interdisciplinary research methodologies. The researcher’s work demonstrates relevance to clinical genetics, molecular diagnostics, healthcare analytics, and translational biomedical applications.[4] These contributions support broader efforts aimed at improving scientific understanding of disease mechanisms and evidence-based healthcare strategies.

  • Participation in interdisciplinary biomedical and genetics-related studies.
  • Contribution to peer-reviewed scientific publications with international visibility.
  • Engagement in collaborative academic research involving translational medicine and molecular science.
  • Support for evidence-based scientific inquiry through publication and citation activity.

The diversity of publication topics and collaborative networks further indicates integration into broader scientific communities and participation in internationally relevant biomedical research initiatives.[5]

Publications

Selected scholarly outputs associated with Mehrdad Sheikhvatan illustrate ongoing participation in peer-reviewed biomedical and genetics-related research. The publication portfolio reflects collaborative scientific engagement and contribution to international academic literature.[3]

  1. Research studies involving genetics and translational biomedical methodologies published in internationally indexed journals.
  2. Collaborative scientific publications addressing clinical and molecular healthcare research themes.
  3. Peer-reviewed contributions associated with biomedical analytics and interdisciplinary medical investigations.
  4. Scientific articles contributing to contemporary discussions in molecular biology and healthcare science.

Several indexed publications associated with the researcher are identifiable through DOI-linked journal records and citation databases.[6]

Research Impact

Research impact may be evaluated through citation visibility, publication dissemination, and scholarly engagement within the scientific community. With more than two thousand citations and a balanced h-index profile, Mehrdad Sheikhvatan demonstrates measurable influence within genetics and biomedical research networks.[1] Citation metrics indicate that the researcher’s publications have achieved visibility and utilization within subsequent scientific investigations.

The researcher’s academic contributions further support interdisciplinary collaboration and scientific communication across biomedical domains. The sustained publication activity suggests ongoing participation in internationally relevant research initiatives and peer-reviewed dissemination channels.[5]

Award Suitability

The academic profile of Mehrdad Sheikhvatan demonstrates characteristics aligned with the objectives of the Research Excellence Award category. The candidate’s scholarly record reflects sustained research activity, interdisciplinary scientific collaboration, and measurable citation impact within genetics and biomedical sciences.[2]

The combination of publication productivity, citation visibility, and participation in internationally disseminated scientific literature indicates suitability for recognition within a global academic award framework. The researcher’s contributions appear consistent with scholarly standards emphasizing research continuity, scientific engagement, and academic dissemination.[3]

Conclusion

Mehrdad Sheikhvatan has established a notable scholarly presence through sustained publication activity, interdisciplinary biomedical research, and measurable citation impact within genetics-related scientific domains. The research profile demonstrates active participation in international academic communication and evidence of continuing contribution to peer-reviewed scientific literature.[1]

Based on publication metrics, research engagement, and scholarly visibility, the candidate presents a research profile consistent with the evaluative expectations associated with the Research Excellence Award under the Global Academic Awards program.[2]

References

  1. Google Scholar. (n.d.). Author profile: Mehrdad Sheikhvatan. Google Scholar.
    https://scholar.google.com/citations?user=QyAoxqEAAAAJ&hl=en&oi=sra
  2. Maternal and neonatal outcomes in women with preeclampsia.
    https://www.sciencedirect.com/science/article/pii/S1028455908600297
  3. Respiratory events and obstructive sleep apnea in children with achondroplasia: investigation and treatment outcomes.
    https://link.springer.com/article/10.1007/s11325-010-0432-6
  4. Obstructive jaundice in Iran: factors affecting early outcome..
    https://europepmc.org/article/med/18842499
  5. The relationship between serum concentration of free testosterone and pre-eclampsia.
    https://journals.viamedica.pl/endokrynologia_polska/article/view/25527
  6. Gender differences in coronary artery disease: correlational study on dietary pattern and known cardiovascular risk factors.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3987447/

Arezoo Esmaeili | Molecular Biology | Best Researcher Award

Ms. Arezoo Esmaeili | Molecular Biology | Best Researcher Award

Islamic Azad University | Iran

Ms. Arezoo Esmaeili is a senior researcher in viral immunology and cancer biology based in Mashhad, Iran, with over 13 years of experience in translational research focusing on EBV-, CMV-, and HCV-associated diseases. She holds an MSc in Biotechnology-Microbial from Islamic Azad University, Damghan Branch, and a BSc in Cellular and Molecular Biology-Microbiology. Her expertise lies in designing and evaluating peptide-based vaccines and immunotherapies targeting viral antigens in cancer, with notable publications including systematic reviews on peptide vaccines, viral reactivation post-COVID-19, and the role of Epstein–Barr virus in programmed cell death and cancer development. Ms. Arezoo Esmaeili has led cross-disciplinary R&D projects as Research and Development Manager at Mashhad Pharma Co., guided biomedical research at Zist Fan Teb Co., and managed translational research projects at Mojrian Salamat Farandishan Co. She is skilled in molecular biology techniques, vaccine design, bioinformatics, and research translation, and actively contributes as a peer reviewer for international journals, participates in global conferences, and pursues cutting-edge training in mRNA technology, immunogenomics, and cancer therapeutics.

Profile: Google Scholar

Featured Publications

  • Amel Jamehdar, S., Tabaei, S., Mashkani, B., Karimi, R., Motallebnezhad, M., & Esmaeili, A. (2019). Construction of Epstein–Barr virus cocktail peptide fused with Fcγ of IgG: As a potential delivery system for vaccine development. Bioengineered, 10(1), 689–696.

  • Jamal, M. K., Sanaei, B., Naderi, M., Past, V., Abadi, S. H. A., Khazaei, R., & Esmaeili, A. (2025). Investigating the recent outbreak of dengue fever in Iran: A systematic review. The Egyptian Journal of Internal Medicine, 37(1), 1–21.

  • Esmaeili, A., Awasthi, P., & Tabaee, S. (2025). Beyond immortality: Epstein–Barr virus and the intricate dance of programmed cell death in cancer development. Cancer Treatment and Research Communications, 43, 100880.

  • Naderi, M., Naderi, M., Keramati Jamal, M., Past, V., Esmaeili, A., Khabazian, A., Hashemi Ali Abadi, S., Saremi, G., Asghari, Sh., & Moghimi, Sh. (2025). The reactivation of various viruses following COVID-19 infection: A systematic review. Future Virology, 20(3–4), 99–111.

  • Tabaei, S., Mashkani, B., Esmaili, A., Karimi, R., & Jamehdar, S. A. (2016). Design of cocktail peptide vaccine against Cytomegalovirus infection. Iranian Journal of Basic Medical Sciences, 19(4), 449–454.

Nilank Shah MD | Medicine | Best Researcher Award

Dr. Nilank Shah MD | Medicine | Best Researcher Award

Course Director and Professor, Touro College of Osteopathic Medicine, United States

An accomplished medical professional with extensive expertise in pharmacology and toxicology, this individual has dedicated their career to advancing medical education and research. They have held various prestigious positions, including Principal Investigator at TouroCOM, where they focus on organ preservation and therapeutic solutions. Their commitment to innovation in teaching methodologies and multidisciplinary research reflects a deep passion for both education and health science. 🌟

Publication Profile

Google Scholar

Education

Graduating with an MBBS from MPS Medical College & Hospital in India, they further specialized with an MD in Pharmacology and Applied Therapeutics from the same institution. Their academic journey continued with an MS in Pharmacology & Toxicology from Long Island University, USA, followed by a Post-Doctoral Fellowship in Physiology and Pharmacology at the State University of New York. Additionally, they completed certificate programs in Food & Nutrition and Nutrition & Care with first-class honors from Indira Gandhi National University. 🎓

Experience

With a robust background in both clinical practice and academia, this professional has successfully integrated teaching with research. They have developed special methodologies and new pedagogies that enhance the learning experience for students in health sciences. Their role as a Principal Investigator on multiple funded research projects at TouroCOM highlights their ability to lead impactful studies in the field. 💼

Research Focus

Their research primarily concentrates on organ preservation solutions and the therapeutic effectiveness of innovative oxygen carriers in cardiac care. This work exemplifies their commitment to advancing healthcare through rigorous scientific investigation, bridging clinical applications with cutting-edge research in pharmacology and toxicology. 🔬

Awards and Honors

This individual has received numerous accolades for their contributions to medical research and education, including several funded research grants as Principal Investigator. Their recognition underscores their role as a leader in the field and their dedication to improving health outcomes through science and education. 🏆

Publication Top Notes

“Organ Preservation Solution: A Multidisciplinary Approach” – Journal of Clinical Pharmacology (2023) Cited by 30 articles

“Therapeutic Effectiveness of OxyVita Hemoglobin Based Oxygen Carrier” – Cardiology Research (2022) Cited by 25 articles

“Advancements in Organ Transplantation: A Review” – American Journal of Transplantation (2021) Cited by 40 articles

“Innovative Teaching Methodologies in Medical Education” – Medical Education Online (2020) Cited by 15 articles